Bioquest Corp

BQST · OTC · SIC 2834: Pharmaceutical Preparations
32
SEC Filings

Business Summary

Description of the Business The following description of our business contains forward-looking statements relating to future events or our future financial or operating performance that involve risks and uncertainties, as set forth above under Special Note Regarding Forward-Looking Statements. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of certain factors described in this Annual Report, including those set forth above in the ...

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionBQSTdiscussed_in_filing Blockchain & Crypto
topic_mentionBQSTdiscussed_in_filing Semiconductor
topic_mentionBQSTdiscussed_in_filing Regulation
topic_mentionBQSTdiscussed_in_filing Healthcare & Bio
topic_mentionBQSTdiscussed_in_filing Platform & Ecosystem
topic_mentionBQSTdiscussed_in_filing Sovereign & Government
topic_mentionBQSTdiscussed_in_filing Blockchain & Crypto
topic_mentionBQSTdiscussed_in_filing Semiconductor
topic_mentionBQSTdiscussed_in_filing Regulation
topic_mentionBQSTdiscussed_in_filing Healthcare & Bio
topic_mentionBQSTdiscussed_in_filing Platform & Ecosystem
topic_mentionBQSTdiscussed_in_filing Sovereign & Government
topic_mentionBQSTdiscussed_in_filing Blockchain & Crypto
topic_mentionBQSTdiscussed_in_filing Semiconductor
topic_mentionBQSTdiscussed_in_filing Regulation
topic_mentionBQSTdiscussed_in_filing Healthcare & Bio
topic_mentionBQSTdiscussed_in_filing Platform & Ecosystem
topic_mentionBQSTdiscussed_in_filing Sovereign & Government
topic_mentionBQSTdiscussed_in_filing Blockchain & Crypto
topic_mentionBQSTdiscussed_in_filing Semiconductor

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2022-08-152022-04-300001493152-22-022442EDGAR23K words
2021-08-132021-04-300001493152-21-019755EDGAR—
2014-08-132014-04-300001019687-14-003096EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2022-09-122022-07-310001493152-22-025605EDGAR9K words
2022-05-272022-01-310001493152-22-015291EDGAR—
2022-05-162021-10-310001493152-22-013407EDGAR—
2022-04-292021-07-310001493152-22-011635EDGAR—
2021-06-152021-01-310001493152-21-014408EDGAR—
2020-12-142020-10-310001493152-20-023565EDGAR—
2015-03-172015-01-310001019687-15-001005EDGAR—
2014-12-152014-10-310001019687-14-004708EDGAR—
2014-09-192014-07-310001019687-14-003636EDGAR—
2014-03-252014-01-310001568628-14-000005EDGAR—
2013-12-172013-10-310001568628-13-000003EDGAR—
2013-10-222013-07-310001477932-13-004756EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2022-05-190001493152-22-014384EDGAR1K words
2020-10-140001493152-20-019434EDGAR—
2015-03-120001019687-15-000920EDGAR—
2014-09-020001019687-14-003416EDGAR—
2014-08-060001019687-14-002986EDGAR—
2014-07-220001019687-14-002780EDGAR—
2014-07-090001019687-14-002690EDGAR—
2014-06-260001019687-14-002561EDGAR—
2014-04-100001477932-14-001645EDGAR—

32 total filings indexed. 8 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001568628
TickerBQST
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: d3d2f940917f0475b3abf2d83accc8ae124a83c367e90a1bc4152cdde4ecc83d
parent: 970fa7826f1d8ff94e5268245a0f74d78232f56be7185a05d7db2c33082add4c
content hash: 269fee05829a7d1419c824d5568f04dd89d5c32392278cdc83631a0b8c8a0de1
signed: 2026-04-13T04:44:04.440Z
sources: 15 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf